Marthe Fourcade

GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.

GSK Plc’s Jemperli helped extend the lives of patients with endometrial cancer in a late-stage test, suggesting the medicine could become the top seller the UK drugmaker is predicting.

A therapy for blood disorders became the first ever gene-editing treatment to get regulatory approval for use on humans in a breakthrough for the technology, which aims to repair genetic code.

GSK Plc said its antibody drug Blenrep, which had its US clearance revoked last year, helped patients live longer without their blood cancer worsening in a late-stage study.

UK health officials have reported a person with a flu strain typically found in pigs, marking the first time this variant has been detected in a human in the country.

Argenx SE shares plunged after the Dutch biotech said preliminary results from a study suggest its only medicine failed in a trial for a rare bleeding disorder.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Roche Holding AG said an experimental medicine helped women with a particular breast cancer mutation live longer without the disease progressing.

Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing.